Overview

The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of the combination of Thalidomide and Huang-Lian-Jie-Du-Tang on the patients with multiple myeloma in maintain therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Wuhan University
Collaborator:
Tongji Hospital
Treatments:
Oren gedoku to
Thalidomide